Management of lipid exudates in Coats disease by adjuvant intravitreal triamcinolone: Effects and complications

British Journal of Ophthalmology

Volumn 94, Issue 5, 2010, Pages 606-610

  Othman, Ihab Saad ^a,b   Moussa, Magdy ^c   Bouhaimed, Manal ^d  

^a Cairo University   (Egypt)

^b National Eye Center   (Egypt)

^c TANTA UNIVERSITY   (Egypt)

^d KUWAIT UNIVERSITY   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

TRIAMCINOLONE;

ADULT; ARTICLE; CATARACT; CATARACT EXTRACTION; CHILD; CLINICAL ARTICLE; CRYOTHERAPY; EXUDATIVE RETINITIS; FEMALE; HUMAN; LASER SURGERY; LENS IMPLANTATION; MALE; PRIORITY JOURNAL; RETINA EXUDATE; SCLEROTOMY; SUBRETINAL FLUID; SURGICAL DRAINAGE; VISUAL ACUITY; VITRECTOMY;

ADOLESCENT; CHEMOTHERAPY, ADJUVANT; CHILD; CHILD, PRESCHOOL; EXUDATES AND TRANSUDATES; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; INFANT; INJECTIONS, INTRAOCULAR; LIPID METABOLISM; MACULAR EDEMA; MALE; RETINAL DETACHMENT; RETINAL DISEASES; RETROSPECTIVE STUDIES; TELANGIECTASIS; TREATMENT OUTCOME; TRIAMCINOLONE; YOUNG ADULT;

EID: 77952194133     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2009.168013     Document Type: Article

References (26)

1. Coats G. On the cause of the ophthalmoscopic appearances in amaurotic family idiocy. Proc R Soc Med 1916;9:30-38.
2. Woods AC, Duke JR. Coats' disease: I: review of literature, diagnostic criteria, clinical findings and plasma lipid studies. Br J Ophthalmol 1964;47:385-412.
3. Coats G. Über Retinitis Exudativa (retinitis hemorrhagica externa). Graefes Archives of Ophthalmology 1912;81:275-327.
4. Gomez Morales A. Disease: natural history and results of treatment. Am J Ophthalmol 1965;60:855-865
5. Kirath H, Eldem B. Management of moderate to advanced disease. Ophthalmologica 1998;212:19-22.
6. Char DH. Syndrome: long term follow up. Br J Ophthalmol 2000;84:37-39
7. Harris GS. Disease, diagnosis and treatment. Can J Ophthalmol 1970;4:311-320
8. Ridley ME, Shields JA, Brown GC, et al. Disease: evaluation of management. Ophthalmology 1982;89:1381-1387
9. Haik BG. Advanced Coats' disease. Trans Am Ophthalmol Soc 1991;89:371-475.
10. Chang M, McLean IW, Merritt JC. Coats' disease: a study of 62 histologically confirmed cases. J Pediatr Ophthalmol Strabismus 1984;21:163-168 (Pubitemid 14046190)
11. Shield JA, Shields CL, Honavar SG, et al. Classification and management of Coats' disease: the 2000 Proctor Lecture. Am J Ophthalmol 2001;131:572-583
12. Tripathi R, Ashton N. Electron microscopical study of disease. Br J Ophthalmol 1971;55:289-301.
13. Spitznas M, Joussen F, Wessing A, et al. Disease: an epidemiologic and fluorescein angiographic study. Albrecht Von Graefes Arch Klin Exp Ophthalmol 1975;195:241-250
14. Penfold PL, Wong JG, Gyory J, et al. Effects of Triamcinolone acetonide on micoglial morphology and quantitative expression of MHC-II in exudative AMD. Clin Experiment Ophthalmol 2001;29:188-192
15. Matsuda S, Gomi F, Oshima Y, et al. Vascular endothelial growth factor reduced and connective tissue growth factor induced by triamcinolone in ARPE19 cells under oxidative stress. Invest Ophthalmol Vis Sci 2005;46:1062-1068 (Pubitemid 41321046)
16. Wang YS, Friedrichs U, Eichler W, et al. Inhibitory effects of Triamcinolone acetonide on bFGF-induced migration and tube formation in choroidal microvascular endothelial cells. Graefes Arch Clin Exp Ophthalmol 2002;240:42-48 (Pubitemid 36075572)
17. Ladjimi A, Zeghidi H, Ben Yahia S, et al. Intravitreal injection of Triamcinolone acetonide for the treatment of macular edema. J Fr Ophtalmol 2005;28:749-757 (Pubitemid 41480591)
18. Jarin RR, Teoh SCB, Lim TH. Resolution of severe macular oedema in adult Coat's syndrome with high-dose intravitreal Triamcinolone acetonide. Eye 2006;20:163-165
19. Martinez JA. Intravitreal Triamcinolone acetonide for bilateral acquired parafoveal telangiectasis. Arch Ophthalmol 2003;121:1658-1659
20. Sun Y, Jain A, Moshfeghi DM. Elevated vascular endothelial growth factor levels in Coats disease: rapid response to pegaptanib sodium. Graefes Arch Clin Exp Ophthalmol 2007;245:1387-1389 (Pubitemid 47278676)
21. Cakir M, Cekiç O, Yilmaz OF. Combined intravitreal bevacizumab and Triamcinolone injection in a child with Coats disease. J AAPOS 2008;12:309-311 (Pubitemid 351853463)
22. Bergstrom CS, Hubbard GB 3rd. Combination intravitreal Triamcinolone injection and cryotherapy for exudative retinal detachments in severe Coats disease. Retina 2008;28:S33-7.
23. Jonas J. Intravitreal Triamcinolone acetonide as treatment for extensive exudative retinal detachment. Br J Ophthalmol 2004;88:587-588 (Pubitemid 38437891)
24. Schefler AC, Berrocal AM, Murray TG. Advanced Coats' disease. Management with repetitive aggressive laser ablation therapy. Retina 2008;28:S38-41.
25. Sallam A, Comer RM, Chang JH, et al. Short-term safety and efficacy of intravitreal Triamcinolone acetonide for uveitic macular edema in children. Arch Ophthalmol 2008;126:200-205 (Pubitemid 351240848)
26. Adam RS, Kertes PJ, Lam WC. Observations on the management of Coats' disease: less is more. Br J Ophthalmol 2007;91:303-306 (Pubitemid 46586523)